Feb 12, 2021

Starpharma signs research agreement with MSD

Starpharma signs research agreement with MSD

The Market Herald reported that Starpharma signed a Research Agreement with Merck & Co., Inc., Kenilworth NJ USA for dendrimer-based Antibody Drug Conjugates (ADCs) utilising Starpharma’s proprietary DEP® technology. Read more here

 This contains certain forward-looking statements.